Thor Medical ASA (OSL:TRMED)

Norway · Delayed Price · Currency is NOK

5.30

-0.36 (-6.36%)

Aug 4, 2026, 4:27 PM CET

112.42% (1Y)

Market Cap	2.04B +131.4%
Revenue (ttm)	839.00K
Net Income	-58.01M
EPS	-0.17
Shares Out	360.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,501,760
Open	5.60
Previous Close	5.66
Day's Range	5.14 - 5.62
52-Week Range	2.34 - 6.03
Beta	-0.23
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2009

Employees 18

Stock Exchange Oslo Børs

Ticker Symbol TRMED

Full Company Profile

Financial Performance

Financial Statements

News

Thor Medical ASA Earnings Call Transcript: H2 2025

AlphaOne remains on track for completion and production ramp-up, supported by a NOK 850 million order backlog and strong market demand for alpha-emitting isotopes. The company is fully funded to reach cash-positive operations by 2027, with significant revenue potential and a growing customer base.

5 months ago - Transcripts

Thor Medical ASA Annual report: H2 2025

Thor Medical ASA has published its H2 2025 annual report on February 26, 2026.

5 months ago - Filings

Thor Medical ASA Quarterly report: H2 2025

Thor Medical ASA has published its H2 2025 quarterly earnings report on February 26, 2026.

5 months ago - Filings

Thor Medical ASA Slides: H2 2025

Thor Medical ASA has posted slides in relation to its H2 2025 quarterly earnings report, which was published on February 26, 2026.

5 months ago - Filings

Thor Medical ASA Earnings Call Transcript: H1 2025

First commercial sales and major strategic agreements validate technology and market position. AlphaOne plant is fully funded, on schedule for 2026, and capacity was expanded by 40% after a successful capital raise. Revenue potential is strong, with a NOK 770 million order backlog and ambitious growth plans.

1 year ago - Transcripts

Thor Medical ASA Quarterly report: H1 2025

Thor Medical ASA has published its H1 2025 quarterly earnings report on August 29, 2025.

1 year ago - Filings

Thor Medical ASA Slides: H1 2025

Thor Medical ASA has posted slides in relation to its H1 2025 quarterly earnings report, which was published on August 29, 2025.

1 year ago - Filings